Biolife Solutions (BLFS) Depreciation & Amortization (CF) (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $374000.0 in Q1 2026.

• On a quarterly basis, Depreciation & Amortization (CF) fell 45.16% year-over-year to $374000.0 in Q1 2026; TTM through Mar 2026 was $1.9 million, a 56.57% decrease from a year earlier, with the FY2025 full-year figure at $2.3 million, down 56.34% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $374000.0, up from $261000.0 in the prior quarter.
• Over the last five years, Depreciation & Amortization (CF) for BLFS reached as high as $2.0 million in Q2 2023 and fell as low as $261000.0 in Q4 2025.
• Historically, Depreciation & Amortization (CF) has averaged $1.3 million across 5 years, with a median of $1.5 million in 2024.
• Across the five-year window, Depreciation & Amortization (CF) soared 112.74% in 2022 and sank 72.15% in 2025, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $1.7 million in 2022, then fell by 14.6% to $1.5 million in 2023, then sank by 36.17% to $937000.0 in 2024, then sank by 72.15% to $261000.0 in 2025, then soared by 43.3% to $374000.0 in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $374000.0 in Q1 2026, $261000.0 in Q4 2025, and $636000.0 in Q3 2025.